Cargando…

Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin

INTRODUCTION: In patients with limited peritoneal metastasis (PM) originating from colorectal cancer, cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment option. This combined treatment modality using HIPEC with mitomycin C (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helderman, Roxan F. C. P. A., Bokan, Bella, van Bochove, Gregor G. W., Rodermond, Hans M., Thijssen, Elsy, Marchal, Wouter, Torang, Arezo, Löke, Daan R., Franken, Nicolaas A. P., Kok, H. Petra, Tanis, Pieter J., Crezee, Johannes, Oei, Arlene L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064448/ https://www.ncbi.nlm.nih.gov/pubmed/37007077 http://dx.doi.org/10.3389/fonc.2023.1122755

Ejemplares similares

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
por: Helderman, Roxan F.C.P.A., et al.
Publicado: (2020)

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
por: Löke, Daan R., et al.
Publicado: (2021)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
por: Löke, Daan R., et al.
Publicado: (2020)

Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2019)

Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom
por: Löke, Daan R., et al.
Publicado: (2023)

Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2022)

Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2021)

PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation
por: IJff, Marloes, et al.
Publicado: (2021)

Hyperthermia-Based Anti-Cancer Treatments
por: Crezee, Johannes, et al.
Publicado: (2021)

A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
por: Van Hattum, J. W., et al.
Publicado: (2022)

Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
por: IJff, Marloes, et al.
Publicado: (2018)

Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
por: Oei, Arlene L., et al.
Publicado: (2015)

The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Crezee, Hans, et al.
Publicado: (2019)

Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Crezee, Johannes, et al.
Publicado: (2020)

Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines
por: Mei, Xionge, et al.
Publicado: (2020)

Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
por: Elming, Pernille B., et al.
Publicado: (2019)

Decay of γ-H2AX foci correlates with potentially lethal damage repair and P53 status in human colorectal carcinoma cells
por: Van Oorschot, Bregje, et al.
Publicado: (2013)

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
por: Oei, Arlene L., et al.
Publicado: (2017)

Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study
por: Benzaquen, Ella, et al.
Publicado: (2021)

Sensitizing thermochemotherapy with a PARP1-inhibitor
por: Oei, Arlene L, et al.
Publicado: (2016)

HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings
por: Agnass, Pierre, et al.
Publicado: (2020)

An Unsupervised Strategy for Identifying Epithelial-Mesenchymal Transition State Metrics in Breast Cancer and Melanoma
por: Klinke, David J., et al.
Publicado: (2020)

Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C
por: Lambert, Laura A., et al.
Publicado: (2009)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020)

An elastic-net logistic regression approach to generate classifiers and gene signatures for types of immune cells and T helper cell subsets
por: Torang, Arezo, et al.
Publicado: (2019)

Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges
por: Buikhuisen, Joyce Y., et al.
Publicado: (2020)

Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature
por: Pinto, Amandine, et al.
Publicado: (2019)

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
por: Conroy, Samantha, et al.
Publicado: (2022)

Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy
por: Leinwand, Joshua C., et al.
Publicado: (2013)

Hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin: Influence of perfusion temperature on postoperative outcome and survival
por: Verhulst, Johanna
Publicado: (2015)

Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
por: Cashin, Peter H, et al.
Publicado: (2020)

A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
por: van Leeuwen, Caspar M., et al.
Publicado: (2017)

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain
por: Plata, Ana, et al.
Publicado: (2021)

Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis
por: Lee, Suk Jun, et al.
Publicado: (2021)

Combined Mucinous and Neuroendocrine Tumours of the Appendix Managed with Surgical Cytoreduction and Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy
por: Hajjar, Roy, et al.
Publicado: (2019)

Is platelet-rich plasma improves the anastomotic healing in hyperthermic intraperitoneal chemotherapy with oxaliplatin: an experimental rat study
por: Buk, Omer Faruk, et al.
Publicado: (2020)

Outcomes of Cytoreduction and Oxaliplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Colorectal Cancer
por: Alhumaid, Moayad, et al.
Publicado: (2021)

A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis
por: Shannon, Nicholas Brian, et al.
Publicado: (2019)

The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review
por: IJff, Marloes, et al.
Publicado: (2022)

Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer
por: Oei, Arlene L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jr8htoa7068n08llrp7b2hu1pr